Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Stroke. 2013 Jul 30;44(10):2710–2717. doi: 10.1161/STROKEAHA.111.000834

Table 2. Distribution of serum fatty acid concentrationsa.

Non-case Case
Common name Q1 Median Q3 Q1 Median Q3 Diffb
18:2n6 Linoleic 24.22 27.12 30.40 23.78 26.73 29.70 *-0.55
16:0 Palmitic 22.07 23.77 25.77 22.56 24.37 26.44 * 0.65
18:1n9 Oleic 16.12 17.59 19.07 16.66 18.17 19.68 * 0.46
18:0 Stearic 7.83 8.54 9.18 7.67 8.42 9.20 -0.06
20:4n6 Arachidonic 7.02 8.27 9.67 6.63 8.01 9.43 *-0.31
16:1n7 7-Hexadecenoic 1.65 2.23 2.96 1.79 2.34 3.09 * 0.15
20:3n6 Dihomo-gamma-linolenic 1.71 2.05 2.40 1.75 2.03 2.34 -0.01
22:6n3 Docosahexaenoic 1.50 1.97 2.65 1.34 1.75 2.32 *-0.26
18:1n7 Vaccenic 1.29 1.47 1.69 1.31 1.49 1.68 0.01
14:0 Myristic 0.64 0.84 1.09 0.66 0.89 1.14 * 0.06
18:1t (no common name) 0.56 0.75 1.03 0.60 0.80 1.05 * 0.05
20:5n3 Eicosapentaenoic 0.44 0.60 0.85 0.40 0.56 0.76 *-0.09
22:5n3 Docosapentaenoic 0.45 0.56 0.68 0.41 0.51 0.63 *-0.05
18:3n3 Alpha-linolenic 0.44 0.55 0.68 0.42 0.53 0.66 *-0.02
18:3n6 Gamma-linolenic 0.32 0.41 0.53 0.31 0.41 0.52 -0.01
16:1t Palmitelaidic 0.27 0.33 0.38 0.28 0.33 0.39 0.001
22:4n6 Adrenic 0.15 0.30 0.43 0.15 0.29 0.42 *-0.005
17:0 Margaric 0.25 0.28 0.32 0.24 0.28 0.32 -0.003
20:2n6 Eicosadienoic 0.22 0.26 0.30 0.22 0.25 0.30 -0.004
22:5n6 (no common name) 0.19 0.25 0.32 0.19 0.24 0.31 *-0.012
15:0 Pentanoic 0.15 0.19 0.23 0.15 0.19 0.23 0.003
20:1n9 Eicosenoic 0.09 0.14 0.24 0.10 0.14 0.26 *0.004
20:4n3 Eicosatetraenoic 0.05 0.08 0.11 0.05 0.07 0.10 *-0.004
18:2tt Linelaidic 0.02 0.03 0.06 0.02 0.04 0.07 * 0.005
24:1n9 Nervonic 0.00 0.00 0.04 0.00 0.00 0.05 -0.004

Q, quartile; Diff, difference; t, trans.

a

Fatty acids are shown in order of median concentration of fatty acids among non-cases.

b

The average of the differences between case and control serum fatty acid concentration.

*

Wilcoxon signed-rank test P ≤ 0.05.